Compare KYN & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KYN | TXG |
|---|---|---|
| Founded | 2004 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.7B |
| IPO Year | N/A | 2019 |
| Metric | KYN | TXG |
|---|---|---|
| Price | $13.61 | $28.50 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 15 |
| Target Price | N/A | ★ $20.25 |
| AVG Volume (30 Days) | 417.2K | ★ 2.7M |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | ★ 8.99% | N/A |
| EPS Growth | N/A | ★ 76.97 |
| EPS | ★ 0.71 | N/A |
| Revenue | N/A | ★ $245,893,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.33 |
| P/E Ratio | $19.48 | ★ N/A |
| Revenue Growth | N/A | ★ 68.06 |
| 52 Week Low | $11.31 | $8.95 |
| 52 Week High | $14.70 | $28.17 |
| Indicator | KYN | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 39.55 | 72.87 |
| Support Level | $12.93 | $19.68 |
| Resistance Level | $14.37 | N/A |
| Average True Range (ATR) | 0.25 | 1.59 |
| MACD | -0.07 | 0.68 |
| Stochastic Oscillator | 3.16 | 94.01 |
Kayne Anderson Energy Infrastructure Fund, Inc is a non-diversified, closed-end fund. Its investment objective is to provide a high after-tax total return with an emphasis on making cash distributions to the stockholder. The Company invests in various sectors, which include midstream energy companies, renewable infrastructure companies, and utility companies. The company seeks to achieve its objectives by investing a majority of its total assets in the securities of Energy Infrastructure companies.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).